Monthly Archives: December 2018

27Dec/18

Immunity: Reveal and Reconstruct A Shortcut to Produce Significant HIV Antibodies with Broad Neutralization

December 27, 2018Antibody ResearchAntibody Research, HIV Antibody, Therapeutic Antibodybio-anti

HIV evades the body’s immune defenses through multiple mutations, and the antibodies against HIV produced by the host’s immune system follow a complex and difficult-to-track evolutionary pathway. This complexity makes it difficultRead More…

08Dec/18

Research on the Action Mechanism of 4-1BB Activated Antibody Makes Advances

December 8, 2018Antibody Application, Antibody ResearchAntibody Discovery, Antibody Research, Tumor Antibodybio-anti

As life lies in movement, immunity relies on balance. A healthy individual has immune cells that can easily eradicate the recurring diseased cells in the body, including those potentially evolving to cancerousRead More…

04Dec/18

CCR4 Targeted Antibody Drug Poteligeo Approved by EC for Lymphoma

December 4, 2018Antibody Application, Antibody News, Antibody ResearchAntibody Production, Immunotherapy Antibody, Monoclonal antibody, Therapeutic Antibodybio-anti

Kyowa Hakko Kirin, a Japanese pharmaceutical company, recently announced that the European Commission (EC) has approved Poteligeo (mogamulizumab) to treat adult patients with relapsed or refractory mycosis fugoides (MF) or Sezary syndromeRead More…